Sep 29 2023 This Week in Cardiology
This Week in Cardiology
Medscape Podcasts
4.9 • 963 Ratings
🗓️ 29 September 2023
⏱️ 26 minutes
🧾️ Download transcript
Summary
Reader feedback, leadless pacing, ABIM, SGLT2 inhibitors, peri-operative MI after cardiac surgery, and. AHA late-breakers are the topics John Mandrola, MD, covers in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Reader Feedback
Sep 22, 2023 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/996694
- ODYSSEY OUTCOMES trial https://www.nejm.org/doi/full/10.1056/nejmoa1801174
- FOURIER https://www.nejm.org/doi/full/10.1056/nejmoa1615664
II. Leadless Pacing
- Leadless vs Transvenous Pacemaker Study https://doi.org/10.1093/europace/euad269
III. ABIM News
Heart Societies Ready to Split From ABIM Over Long-Standing MOC Disputes
https://www.medscape.com/viewarticle/996747
IV. SGLT2 inhibitors
Empagliflozin Gets FDA Nod for CKD Without T2D or HF
https://www.medscape.com/viewarticle/996873
- EMPA-Kidney https://www.nejm.org/doi/full/10.1056/NEJMoa2204233
V. Peri-Op MI after Cardiac Surgery
Cardiac Troponin Predicts Mortality Post Surgery
https://www.medscape.com/viewarticle/996877
- Austrian Perioperative MI study https://doi.org/10.1016/j.jacc.2023.07.011
- Vision https://www.nejm.org/doi/10.1056/NEJMoa2000803
VI. AHA Late Breakers
- Link to Late-Breakers https://professional.heart.org/en/meetings/scientific-sessions/programming/late-breaking-science#late-breaking
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
Transcript
Click on a timestamp to play from that location
| 0:00.0 | You're listening to this week in cardiology from the heart |
| 0:03.4 | org medscape cardiology this podcast is intended for health care |
| 0:07.6 | professionals only any views expressed are the presenters own and do not |
| 0:11.2 | necessarily reflect the views of WebMD or Medscape. |
| 0:15.1 | You can now access the latest in medical news on your Amazon Alexa-enabled device. |
| 0:19.7 | Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I highlight the top |
| 0:24.8 | medical stories of the day. |
| 0:26.6 | To add Medscape Medical Minute to your flash briefing, search for Medscape Medical |
| 0:30.1 | Minute on Amazon and click enable or open the Amazon Alexa app go to skills |
| 0:34.7 | search for Medscape Medical Minute and click enable then say Alexa what's the |
| 0:40.1 | news or Alexa what's my flash briefing I hope you'll join us. |
| 0:44.0 | Hi everyone this is John Mandrola from the heart |
| 0:47.7 | or medscape and this is this week in |
| 0:51.0 | creology for September 29th, 2023. |
| 0:55.0 | This week I'll do some reader feedback, talk about leadless pacemakers, |
| 1:01.0 | A BIM, SGLT 2 and Ambition, Parioperative M I after cardiac surgery, and the AHA has announced |
| 1:11.0 | their late-breaking clinical trials for meeting coming up in six weeks. |
| 1:16.0 | First, some reader feedback. |
| 1:19.0 | Matt Gross left a comment reminding me that I misspoke regarding the Alarocumab trial called Odyssey |
| 1:25.1 | Outcomes. I said that CB death and death were similar but in fact Matt was |
| 1:30.9 | right that overall death was actually lower in the Alarokima group. It was 3.5 versus 4.1 percent. |
| 1:39.0 | I also agree with Matt that this was a likely spurious finding as there was no difference in |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

